Finally, to address potential positive or negative effects of preexisting cross-reactive memory T cells, we compared 25-μg mRNA-1273 COVID-19 vaccine responses between subjects with or without measurable preexisting SARS-CoV-2 spike–reactive memory CD4+ T cells. The gene discussed is CD4; the disease is COVID-19.